Health Condition 1: null- Psychiatric patients
Conditions
Interventions
Intervention1: PROPOFOL: induction agent
Dose 1 mg/kg iintra-venous administration
Frequency depends on therapeutic response (as decided by physician)
Control Intervention1: ETOMIDATE: Induction age
Sponsors
Samiksha kumari
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adult patients of equal number of males and females, aged between 18 to 55 years. 2) Patients belonging to American Society of Anesthesiologist Grade I and II. 3) Patients scheduled for electroconvulsive therapy.
Exclusion criteria
Exclusion criteria: 1) Patient or relatives refusal for electroconvulsive therapy or both. 2) Patients with known allergy to the study drug. 3) Patients with full stomach, neuromuscular disorders, displaced bone fractures, severe osteoporosis. 4) Patients with history of recent myocardial infarction ( 5) Patients with epilepsy 6) Patients with hypopituitarism and major illnesses like bronchial asthma and tuberculosis. 7) Pregnant patients. 8) Agitated patients requiring additional sedation. 9) ASA grade III and IV patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of motor seizure duration in isolated limb in seconds for both the drugsTimepoint: Measurement of motor seizure duration in isolated limb in seconds just after giving electric shock for both the drugs | — |
Secondary
| Measure | Time frame |
|---|---|
| Recovery parameters Any side effectsTimepoint: Intra-operatively and after every 5 min after the procedure | — |
Countries
India
Contacts
Public ContactDr Seema Jindal
Guru Gobind Singh Medical College and Hospital, Faridkot
Outcome results
None listed